Ulf Rosén joined the Board of Directors at TFS International in 2006.
Ulf is General Partner of Danish SEED Capital Management A/S where he is responsible for the group's medtech investments. He is chairman and board member of several companies based in Scandinavia: Chairman of Life Science Management Group/RTC AB; Chairman of LobSor Holding/LobSor Pharmaceutical; and board member of Reapplix ApS , Acarix A/S and Alkalon A/S.
Ulf’s previous operative positions include President & CEO of NeoPharma AB (publ); General Manager of Fresenius-Kabi AB; Executive Vice President Global Nutrition Division at Fresenius-Kabi; and, President & CEO of Pharmacia & Upjohn in Norway. In addition, he has held Chairman and board memberships with several life science companies including board member of Connect Uppsala and Vice Chairman of the Swedish Trade Association, IML.